Long-term changes of body weight and cardiovascular risk factors after weight reduction with group therapy and dexfenfluramine.

Pfohl, M; Luft, D; Blomberg, I; Schmülling, R M

Pfohl, M; Luft, D; Blomberg, I; Schmülling, R M.

Affiliation

Pfohl M; Department of Internal Medicine IV, University of Tübingen, Germany.

Int J Obes Relat Metab Disord ; 18(6): 391-5, 1994 Jun.

Article in En | MEDLINE | ID: mdl-8081430

Subject(s)

Body Weight; Cardiovascular Diseases/etiology; Fenfluramine/therapeutic use; Obesity/drug therapy; Weight Loss; Adult; Blood Glucose/metabolism; Body Mass Index; Cholesterol/blood; Female; Germany; Humans; Male; Risk Factors; Triglycerides/blood

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Body Weight / Cardiovascular Diseases / Weight Loss / Fenfluramine / Obesity Type of study: Clinical_trials / Etiology_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Int J Obes Relat Metab Disord Year: 1994 Document type: Article Affiliation country: Germany

Search on Google

Add to My VHL

XML

PubMed Links